Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 0 | (131) | 515 | 33 |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- |
Operating Expenses | ||||
Research Development | 6,450 | 7,566 | 19,842 | 4,573 |
Selling General and Administrative | 2,161 | 1,973 | 1,699 | 1,694 |
Non Recurring | -- | -- | -- | -- |
Others | (1,187) | (1,118) | 0 | 0 |
Total Operating Expenses | 7,424 | 8,421 | 21,541 | 6,267 |
Operating Income or Loss | (7,424) | (8,552) | (21,026) | (6,234) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (94) | (11) | 23 | 744 |
Earnings Before Interest And Taxes | (7,424) | (8,552) | (21,026) | (6,234) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (7,766) | (8,810) | (21,002) | (5,490) |
Income Tax Expense | -- | -- | -- | -- |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | (7,766) | (8,810) | (21,002) | (5,490) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | (7,766) | (8,810) | (21,002) | (5,490) |
Preferred Stock And Other Adjustments | -- | 3,141 | 3,141 | -- |
Net Income Applicable To Common Shares | (7,766) | (8,810) | (24,143) | (5,490) |